Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
Logan Hamilton, Freelance Writer, shared a post on LinkedIn:
“Vaccine hesitancy often grows from misleading or conspiratorial claims.
Yet, rare vaccine side effects can still occur.
Previous research confirmed dangerous blood clots after some COVID-19 vaccinations. These clots appeared only after administration of adenovirus-based COVID-19 vaccines.
Scientists have now identified a likely cause of these symptoms, known as vaccine-induced thrombocytopenia and thrombosis (VITT). The team discovered a mutated antibody gene that causes VITT symptoms.
This gene was delivered by adenovirus COVID-19 vaccines. Results showed the mutation triggered rare but dangerous blood clotting.
VITT is extremely rare among vaccinated individuals. It occurred in about one in 200,000 recipients. Only adenovirus-based COVID-19 vaccines showed this risk. mRNA COVID-19 vaccines did not show the same pattern.”
Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines